Kelly Shanly

Kelly Shanly is an experienced professional in the pharmaceutical industry with a focus on patient access and regional management. Currently serving as the Executive Director of Patient Access at Neurocrine Biosciences since December 2016, Kelly has held various leadership roles including Director of Patient Access - East and Regional Specialty Manager. Prior experience includes serving as Regional Business Manager at Avanir Pharmaceuticals, managing multiple regions in New York and Pennsylvania, and holding positions such as Divisional Manager and Regional Sales Trainer at Actavis and Forest Pharmaceuticals, respectively. Kelly Shanly holds a Bachelor of Science degree in Corporate Communications from Ithaca College.